Sequenta is a commercial-stage biotech company focused on harnessing the adaptive immune system to transform the diagnosis and treatment of diseases. The company operates in the life sciences research, clinical diagnostics, and drug discovery markets. Sequenta's proprietary immune medicine platform decodes the genetics of the adaptive immune system with unprecedented scale, precision, and speed, enabling the development of personalized clinical products. The company serves healthcare providers, research institutions, and pharmaceutical companies. Sequenta generates revenue through the commercialization of its diagnostic and therapeutic products, as well as partnerships with industry leaders.

Keywords: biotech, immune system, diagnostics, therapeutics, personalized medicine, life sciences, clinical products, drug discovery, healthcare, precision health.